Skip to main content

Experience with Biosynthetic Growth Hormone

  • Chapter
Book cover From Clone to Clinic

Part of the book series: Developments in Biotherapy ((DIBI,volume 1))

  • 99 Accesses

Abstract

After a short review of the history of pituitary growth hormone the effects of the availability of biosynthetic growth hormone are described. Possible benefits, particularly the hope to relieve some of the distress of short children, are weighed against possible risks, a.o. the uncertainties about effects and side-effects and the high cost. Under these circumstances we have chosen for a strategy of concerted action by the medical professionals directly envolved: well-planned prospective long-term studies and thorough retrospective analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wit, J.M. (1986) ‘Responses to growth hormone’. Academic Thesis. State University, Utrecht.

    Google Scholar 

  2. Spiliotis, B.E., August, G.P., Hung, W. et al. (1984) ‘Growth hormone neurosecretory dysfunction. A treatable cause of short stature’. JAMA 251, 2223–2230.

    Article  PubMed  CAS  Google Scholar 

  3. Rose, S.R., Ross, J.L., Uriarte, M.U. et al (1988) ‘The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency’. N Engl J Med 319, 201–207.

    Article  PubMed  CAS  Google Scholar 

  4. Kastrup, K.W., Christiansen, J.S., Anderson, J.K. et al. (1983) ‘Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children’. Acta Endocrinol (Copenh) 104, 148–152.

    CAS  Google Scholar 

  5. Jorgensen, J.O.L., Flyvbjerg, A., Lauritzen, T. et al. ‘Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients’. (1988) J Clin Endocrinol Metab 67, 36–40.

    Article  PubMed  CAS  Google Scholar 

  6. Brown, P. (1988) ‘Human growth hormone therapy and CreutzfeldtJakob Disease: A drama in three acts’. Pediatrics 81, 85–92.

    PubMed  CAS  Google Scholar 

  7. Seeburg, P.H., Shine, J., Martial, J.A. et al. (1978) ‘Synthesis of growth hormone by bacteria’. Nature 276, 795–798.

    Article  PubMed  CAS  Google Scholar 

  8. Rosenfeld, R.G., Hintz, R.L., Johanson, A.J. et al. (1988) Three year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. J Pediatr 113, 393–400.

    Article  PubMed  CAS  Google Scholar 

  9. Rongen-Westerlaken, C., Fokker, M.H., Wit, J.M. et al (1990) ‘Two year results of treatment with methionyl human growth hormone in girls with Turner syndrome’. Acta Paediatr Scand, in press.

    Google Scholar 

  10. Wit, J.M., Fokker, M.H., de Muinck Keizer Schrama, S.M.P.F. et al (1989) ‘Effects of two years of methionyl growth hormone therapy in two dosage regimens in prepubertal children with short stature, subnormal growth rate and normal growth hormone response to secretagogues’. J Pediatr. 115, 720–725.

    Article  PubMed  CAS  Google Scholar 

  11. Koch, V.H., Lippe, B.M., Nelson, P.A. et al (1989) ‘Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure’. J Pediatr 115, 365–371.

    Article  PubMed  CAS  Google Scholar 

  12. De Muinck Keizer-Schrama, S.M.P.F., Hokken-Koelega, A.C.S., Drop, S.L.S. et al. (1989) ‘Dose-response study with biosynthetic growth hormone (GH) in growth hormone deficient (GHD) children’. Hormone Research, 3151;34.

    Google Scholar 

  13. Jorgensen, J.O.L., Thuesen, L., Ingemann-Hansen, T. et al (1989) ‘Beneficial effects of growth hormone treatment in GH-deficient adults’. The Lancet 1, 1221–1224.

    Article  CAS  Google Scholar 

  14. Binnerts, A., Wilson, J.H., Lamberts, S.W. (1988) ‘The effects of human growth hormone administration in elderly adults with recent weight loss’. J Clin Endocrinol Metab 67, 1312–1316.

    Article  PubMed  CAS  Google Scholar 

  15. Lantos, J., Siegler, M., Cuttler, L. (1989) ‘Ethical issues in growth hormone therapy’. JAMA 261, 1020–1024.

    Article  PubMed  CAS  Google Scholar 

  16. Law, C.M. (1987) ‘The disability of short stature’. Arch Dis Child. 62, 855–859.

    Article  PubMed  CAS  Google Scholar 

  17. Wit, J.M., Hughes, M.J. (1988) ‘Development of a software program providing a data-base and enabling mathematical handling and graphical presentation of growth data’. Pediatric Research 24, 528.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Wit, J.M. (1990). Experience with Biosynthetic Growth Hormone. In: Crommelin, D.J.A., Schellekens, H. (eds) From Clone to Clinic. Developments in Biotherapy, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3780-5_29

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3780-5_29

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5683-0

  • Online ISBN: 978-94-011-3780-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics